JNJ

238.68

-0.55%↓

UNH

274.9

-0.55%↓

TMO

546.83

+0.89%↑

ABT

111.08

+0.23%↑

ISRG

492.83

+1.14%↑

JNJ

238.68

-0.55%↓

UNH

274.9

-0.55%↓

TMO

546.83

+0.89%↑

ABT

111.08

+0.23%↑

ISRG

492.83

+1.14%↑

JNJ

238.68

-0.55%↓

UNH

274.9

-0.55%↓

TMO

546.83

+0.89%↑

ABT

111.08

+0.23%↑

ISRG

492.83

+1.14%↑

JNJ

238.68

-0.55%↓

UNH

274.9

-0.55%↓

TMO

546.83

+0.89%↑

ABT

111.08

+0.23%↑

ISRG

492.83

+1.14%↑

JNJ

238.68

-0.55%↓

UNH

274.9

-0.55%↓

TMO

546.83

+0.89%↑

ABT

111.08

+0.23%↑

ISRG

492.83

+1.14%↑

Home・Akcijų sąrašas・Evolent Health Inc

Evolent Health Inc

Uždarymo kaina

SektoriusSveikatos priežiūra

2.72 -3.89

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

2.68

Max

2.83

Pagrindiniai rodikliai
By Trading Economics
Pajamos	30M -21M
Pardavimai	35M 480M
Pelno marža	-4.351
Darbuotojai	4,500
EBITDA	512K 15M

Rekomendacijos
By TipRanks
Rekomendacijos	Stiprus pirkimas
12 mėnesių prognozė	+190.18% upside

Dividendai
By Dow Jones
Kitas uždarbis	2026-02-24

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	-401M 378M
Ankstesnė atidarymo kaina	6.61
Ankstesnė uždarymo kaina	2.72

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Very Strong Bullish Evidence

10.33 / 10.95 Palaikymas ir pasipriešinimas

Evolent Health Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-02-09 17:25; UTC

Įsigijimai, susijungimai, perėmimai

Eli Lilly to Buy Biotech Orna Therapeutics for Up to $2.4 Billion -- Update

2026-02-09 23:46; UTC

Rinkos pokalbiai

Nikkei May Rise on Hopes for Domestic Policy Measures -- Market Talk

2026-02-09 23:43; UTC

Rinkos pokalbiai

Gold Falls on Possible Technical Correction -- Market Talk

2026-02-09 23:14; UTC

Rinkos pokalbiai

WiseTech's Bull Reckons AI-Driven Selloff Is Overdone -- Market Talk

2026-02-09 22:29; UTC

Rinkos pokalbiai

Australian Coking Coal Price Seen Falling Once Supply Disruptions Ease -- Market Talk

2026-02-09 22:19; UTC

Rinkos pokalbiai

Pro Medicus's Business Case Made More Compelling by AI Adoption -- Market Talk

2026-02-09 22:08; UTC

Rinkos pokalbiai

Minerals 260 Bull Bets on Production Scale, Takeover Appeal -- Market Talk

2026-02-09 22:01; UTC

Uždarbis

Friedman Industries Sees 4Q Sales Volume to Generally Consistent With 3Q, With Sequential Improvement in Sales Margins

2026-02-09 21:59; UTC

Uždarbis

Friedman Industries: Hedging Activities Continued to Perform as Anticipated by Mitigating Impact of Commodity Price Volatility

2026-02-09 21:59; UTC

Uždarbis

Friedman Industries: Average Selling Prices Began to Improve as Quarter Progressed

2026-02-09 21:58; UTC

Uždarbis

Friedman Industries 3Q Sales $168M >FRD

2026-02-09 21:50; UTC

Rinkos pokalbiai

Įsigijimai, susijungimai, perėmimai

Financial Services Roundup: Market Talk

2026-02-09 21:50; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2026-02-09 21:48; UTC

Uždarbis

Friedman Industries 3Q EPS 43c >FRD

2026-02-09 21:17; UTC

Uždarbis

Kyndryl Stock Drops 55%. It's So Much Worse Than an Earnings Miss. -- Barrons.com

2026-02-09 21:13; UTC

Rinkos pokalbiai

U.S. Ethanol Crush Margins Near Break-Even -- Market Talk

2026-02-09 21:04; UTC

Uždarbis

Retail Sales Data Should Confirm a Robust Holiday Season -- Barrons.com

2026-02-09 20:30; UTC

Rinkos pokalbiai

Oil Futures Gain As U.S.-Iran Risk Premium Holds -- Market Talk

2026-02-09 20:02; UTC

Rinkos pokalbiai

U.S. Natural Gas Falls on Warmer Weather Outlook -- Market Talk

2026-02-09 19:42; UTC

Rinkos pokalbiai

Japan's Yield Curve Expected to Flatten -- Market Talk

2026-02-09 19:31; UTC

Rinkos pokalbiai

Nike Seen Regaining Relevance With Consumers -- Market Talk

2026-02-09 19:27; UTC

Rinkos pokalbiai

Gold Climbs Back Over $5,000/oz -- Market Talk

2026-02-09 19:05; UTC

Rinkos pokalbiai

Nike Returns to List of Hottest Brands -- Market Talk

2026-02-09 18:19; UTC

Rinkos pokalbiai

Lower Dollar Doesn't Translate to Boost in Grains -- Market Talk

2026-02-09 17:41; UTC

Uždarbis

Įsigijimai, susijungimai, perėmimai

These Stocks Are Today's Movers: Kyndryl, Hims & Hers, Novo Nordisk, AppLovin, Monday.com, Valaris, and More -- Barrons.com

2026-02-09 17:31; UTC

Uždarbis

Įsigijimai, susijungimai, perėmimai

These Stocks Are Today's Movers: Kyndryl, Hims & Hers, Novo Nordisk, Monday.com, Valaris, Cleveland-Cliffs, and More -- Barrons.com

2026-02-09 17:20; UTC

Rinkos pokalbiai

Įsigijimai, susijungimai, perėmimai

Financial Services Roundup: Market Talk

2026-02-09 17:20; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2026-02-09 17:17; UTC

Rinkos pokalbiai

Century Aluminum Announces Next Steps of Okla. Project -- Market Talk

2026-02-09 17:16; UTC

Uždarbis

Kyndryl Stock Drops 56%. It's So Much Worse Than an Earnings Miss. -- Barrons.com

Akcijų palyginimas

Kainos pokytis

Evolent Health Inc Prognozė

Kainos tikslas

By TipRanks

190.18% į viršų

12 mėnesių prognozė

Vidutinis 8.27 USD 190.18%

Aukščiausias 12 USD

Žemiausias 5 USD

Remiantis 13 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Evolent Health Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

13 ratings

Pirkti

Laikyti

Parduoti

Remiantis 13 analitikų, pateikusių Evolent Health Inc akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Techninis įvertinimas

By Trading Central

10.33 / 10.95Palaikymas ir pasipriešinimas

Recent bullish events outweigh bearish events.

All events are bullish.

All events are bearish.

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

Apie bendrovę Evolent Health Inc

Evolent Health, Inc., through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides holistic total cost of care management. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.